Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders
ConditionMTBI - Mild Traumatic Brain Injury
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-35
SponsorSalus University
About this trial
The specific aim of this project is to validate clinical tests to be used as outcome measures in studies of mTBI-related vision problems.
Eligibility criteria
Qualifiers
Diagnosis of mTBI within previous 1 to 6 months
Distance visual acuity better than or equal to 20/25 in each eye
Score >21 on Convergence Insufficiency Symptom Survey
Disqualifiers
Diagnosis of moderate or severe TBI; > 30-min loss of consciousness
Not wearing required refractive error)
Disease(s) known to affect oculomotor system (multiple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, or Parkinson disease)-Manifest strabismus or intraocular injury (evaluated at vision examination)
Cognitive delays that may impact testing
Trial design
Treatments tested in this trial
- Not listed
Trial groups
150 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov